ESC Premium Access

Association of circulating apoptotic (annexin V+) microparticles with ventricular fibrosis and diastolic dysfunction in atrial fibrillation patients with heart failure with preserved ejection fraction

Presentation

About the speaker

Associate Professor Mikhail Dzeshka

Grodno State Medical University, Grodno (Belarus)
0 follower

8 more presentations in this session

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation: a propensity-weighted cohort study

Speaker: Associate Professor E. Grove (Aarhus, DK)

Thumbnail

Evaluation of the effect of oral anticoagulants on all-cause mortality within 3 months of the diagnosis of atrial fibrillation: results from the GARFIELD-AF prospective registry

Speaker: Ms K. Pieper (London, GB)

Thumbnail

Two-year outcomes of dabigatran etexilate in patients with atrial fibrillation with and without a history of coronary artery disease: data from GLORIA-AF

Speaker: Professor G. Lip (Liverpool, GB)

Thumbnail

Impact of age > 75 years on one-year events in patients with atrial fibrillation and left atrial appendage occluder implantation. Results of the prospective LAARGE Registry

Speaker: Professor U. Zeymer (Ludwigshafen, DE)

Thumbnail

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients: the dose subgroup analysis of the ARISTOPHANES study

Speaker: Doctor X. Li (Princeton, NJ, US)

Thumbnail

Access the full session

Poster Session 3 - Atrial fibrillation - Stroke prevention - General

Speakers: Associate Professor M. Dzeshka, Associate Professor E. Grove, Ms K. Pieper, Professor G. Lip, Professor U. Zeymer...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk